Human Milk Oligosaccharides and Respiratory Syncytial Virus Infection in Infants
Authors:
- Karina M TononKTKarina M Tonon
- Somchai ChutipongtanateSCSomchai Chutipongtanate
- Ardythe L MorrowAMArdythe L Morrow
- David S NewburgDNDavid S Newburg
Open Access
- 5 April 2024
- journal article
- Published by Elsevier in Advances in Nutrition
- Vol. 15 (6)
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- Viruses and Human Milk: Transmission or Protection?Advances in Nutrition, 2023
- Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitisEBioMedicine, 2022
- Revisiting respiratory syncytial virus’s interaction with host immunity, towards novel therapeuticsCellular and Molecular Life Sciences, 2020
- The journey to a respiratory syncytial virus vaccineAnnals of Allergy, Asthma & Immunology, 2020
- Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infantsEuropean Journal of Pediatrics, 2017
- Human Milk Oligosaccharides (HMOS)2015
- Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy—a reviewVirus Genes, 2006
- Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infantsThe Journal of Pediatrics, 2004
- Survival of Human Milk Oligosaccharides in the Intestine of Infants2001
- Purification of the Lewis blood-group gene associated ?-3/4-fucosyltransferase from human milk: an enzyme transferring fucose primarily to Type 1 and lactose-based oligosaccharide chainsGlycoconjugate Journal, 1992